Aarti Pharmalabs Board Meeting for Q2 FY27 Results

Key Dates

• Board Meeting Date: Wednesday, October 28, 2026
• Trading Window Closure Period: October 1, 2026 to October 30, 2026 (inclusive)

Agenda Items

The Board of Directors of Aarti Pharmalabs Limited will consider and approve:

• Unaudited Financial Results (standalone) for the quarter ended September 30, 2026
• Unaudited Financial Results (standalone) for the half year ended September 30, 2026
• Unaudited Financial Results (consolidated) for the quarter ended September 30, 2026
• Unaudited Financial Results (consolidated) for the half year ended September 30, 2026
• Limited Review Reports of the Auditors for the corresponding period

Financial Impact

Financial impact not quantified in the disclosure. The meeting is scheduled to consider and approve financial results which will be disclosed separately.